Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-21: an interleukin-2 dependent player in rejection processes.

Carla C Baan1, Aggie H M M Balk, I Esmé Dijke

  • 1Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, the Netherlands. c.c.baan@erasmusmc.nl

Transplantation
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS-CoV-2 With ACE2-Inhibiting Activity Following mRNA Vaccination.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination.

Npj viruses·2026
Same author

Modeling kidney fibrosis and tubular regeneration in iPSC-derived kidney organoids.

Stem cell research & therapy·2025
Same author

BCL6 inhibition: a promising approach to prevent germinal center-driven allo-immune responses.

Frontiers in immunology·2025
Same author

A Comprehensive Assessment of Plasma CXCL9 and CXCL10 in Improving Clinical Prediction Models for Kidney Allograft Rejection.

Clinical transplantation·2025
Same author

Kidney-derived Urinary Extracellular Vesicles are Increased During Acute Rejection after Kidney Transplantation: A Pilot Study.

Transplantation direct·2025

Interleukin-21 (IL-21) is crucial for IL-2 dependent immune responses, acting as a costimulator for T-cell proliferation and cytotoxicity. Blocking the IL-21 pathway offers a novel therapeutic strategy for allogeneic responses in transplant patients.

Area of Science:

  • Immunology
  • Molecular Biology
  • Transplantation Science

Background:

  • Interleukin-21 (IL-21) is a recently identified cytokine produced by activated CD4+ T-cells.
  • IL-21 signals through the common cytokine receptor gamma chain (gammac) and regulates CD8+ T-cell function.
  • This study investigates the role of IL-21 in alloreactivity, particularly in the context of other gammac-dependent cytokines.

Purpose of the Study:

  • To explore the actions of IL-21 in alloreactivity alongside other gammac-dependent cytokines.
  • To investigate the expression of IL-21 and its receptor (IL-21R alpha-chain) in T-cells and heart transplant biopsies.
  • To determine the functional role of IL-21 in T-cell proliferation and cytotoxicity.

Main Methods:

  • mRNA expression of IL-21, IL-21R alpha-chain, and IL-2 was measured in mixed lymphocyte reactions.

Related Experiment Videos

  • Expression of IL-21 and IL-21R alpha-chain was analyzed in heart transplant biopsies.
  • Functional assays involved blocking IL-2 or IL-21 pathways to assess T-cell responses.

    • Main Results:

    • A 10-fold induction of IL-21 and IL-21R alpha-chain mRNA was observed in allostimulated T-cells.
    • IL-21 induction was highly dependent on IL-2; immunosuppressive drugs inhibited IL-21 transcription.
    • IL-21 costimulated IL-2 to enhance T-cell proliferation and cytotoxicity; blockade of IL-2 or IL-21 pathways abrogated these effects.
    • Elevated intragraft IL-21, IL-21R alpha-chain, and IL-2 mRNA levels correlated with acute rejection in heart transplant patients.

    Conclusions:

    • IL-21 is a critical cytokine for IL-2-dependent immune processes.
    • The IL-21 pathway plays a significant role in T-cell mediated alloreactivity.
    • Targeting the IL-21 pathway presents a potential therapeutic strategy for managing allogeneic responses post-transplantation.